Every day counts: why pharmaceutical companies in the EU need to make sure they get the right SPC term
This article was originally published in SRA
Executive Summary
Pharmaceutical companies using the centralised authorisation procedure in the EU may be entitled to a slightly a longer supplementary certificate procedure term than they might think, says Mike Snodin.